A 3‑phase CT scan of the kidney is a specialized contrast-enhanced CT performed in three timed acquisitions: non‑contrast, corticomedullary (early arterial, ~30–40 seconds) and nephrographic (parenchymal, ~90–100 seconds) phases. It uses IV contrast to characterize lesions, distinguish cysts from solid tumors, assess vascularity, detect stones or bleeding, and stage renal cancer or evaluate trauma.

A CT KUB is a low‑dose computed tomography scan of the kidneys, ureters and bladder that produces cross‑sectional X‑ray images of the urinary tract. Often performed without contrast to detect kidney stones, it also identifies obstruction, infection, masses or trauma. The exam is quick, noninvasive, involves radiation, and may need simple prep or contrast for specific indications.

A 3‑phase CT scan acquires three image sets at different times after IV contrast: a pre‑contrast (baseline) series, an arterial (early) phase, and a venous/portal‑venous (later) phase. Timing shows how organs and lesions enhance, improving detection and characterization of liver, kidney, pancreatic and vascular conditions. It requires IV contrast and carries small risks like allergic reaction or contrast‑related kidney injury.

Triple-phase CT urography acquires three image sets: an unenhanced phase to detect stones, hemorrhage and baseline density; a contrast-enhanced parenchymal (corticomedullary/nephrographic) phase to assess renal cortex, medulla and tumor enhancement; and a delayed excretory phase to opacify calyces, pelvis, ureters and bladder for urothelial lesions or leaks. Typical timing: unenhanced, early post-contrast (~30–100 s) and delayed (~5–15 min).

A triple‑phase CT (non‑contrast plus arterial and portal‑venous phases) uses rapid, timed scans after IV contrast. Each acquisition takes seconds, with phases spaced over about 1–5 minutes. The entire appointment — including IV setup, contrast injection and breath‑hold instructions — usually lasts about 15–30 minutes; actual scanner time is only a few minutes.

Yes. CT scans—especially contrast-enhanced studies—can show many types of kidney damage: lacerations, hematomas, contusions, stones, tumors, hydronephrosis, cortical scarring, and changes in size or perfusion. They are the preferred cross-sectional tool for trauma and structural abnormalities. However, subtle functional impairment or very early chronic disease may require blood/urine tests or specialized functional renal imaging.